# Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer

> **NCT04755738** · PHASE2 · UNKNOWN · sponsor: **Qianfoshan Hospital** · enrollment: 234 (estimated)

## Conditions studied

- Advanced Non Small Cell Lung Cancer

## Interventions

- **COMBINATION_PRODUCT:** Almonertinib plus microwave ablation

## Key facts

- **NCT ID:** NCT04755738
- **Lead sponsor:** Qianfoshan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 234 (ESTIMATED)
- **Last updated:** 2021-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04755738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04755738, "Almonertinib Plus Microwave Ablation in Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-08-23 from https://api.ai-analytics.org/clinical/NCT04755738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*